| The EphA2 receptor is activated through induction of distinct, ligand-dependent oligomeric structures DR Singh, P Kanvinde, C King, EB Pasquale, K Hristova Communications biology 1 (1), 15, 2018 | 81 | 2018 |
| Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease AA Date, G Halpert, T Babu, J Ortiz, P Kanvinde, P Dimitrion, J Narayan, ... Biomaterials 185, 97-105, 2018 | 80 | 2018 |
| Preclinical evaluation of intravesical cisplatin nanoparticles for non–muscle-invasive bladder cancer M Kates, A Date, T Yoshida, U Afzal, P Kanvinde, T Babu, NA Sopko, ... Clinical Cancer Research 23 (21), 6592-6601, 2017 | 46 | 2017 |
| Local enema treatment to inhibit FOLH1/GCPII as a novel therapy for inflammatory bowel disease AA Date, R Rais, T Babu, J Ortiz, P Kanvinde, AG Thomas, ... Journal of Controlled Release 263, 132-138, 2017 | 24 | 2017 |
| Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment N Pandey, P Anastasiadis, CP Carney, PP Kanvinde, GF Woodworth, ... Advanced Drug Delivery Reviews 188, 114415, 2022 | 23 | 2022 |
| An ion‐paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection A Josyula, R Omiadze, K Parikh, P Kanvinde, MB Appell, P Patel, ... Bioengineering & Translational Medicine 6 (3), e10238, 2021 | 10 | 2021 |
| Leveraging the replication‐competent avian‐like sarcoma virus/tumor virus receptor‐A system for modeling human gliomas PP Kanvinde, AP Malla, NP Connolly, F Szulzewsky, P Anastasiadis, ... Glia 69 (9), 2059-2076, 2021 | 10 | 2021 |
| Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer AA Date, M Kates, T Yoshida, T Babu, U Afzal, P Kanvinde, A Baras, ... Drug Delivery and Translational Research 11, 2085-2095, 2021 | 3 | 2021 |
| Surface-modified nanodrug carriers for brain cancer treatment AS Wadajkar, NP Connolly, CP Carney, PP Kanvinde, JA Winkles, ... Nanotherapy for Brain Tumor Drug Delivery, 127-144, 2021 | 2 | 2021 |
| TWEAK-Fn14 signaling in glioblastoma-associated myeloid cells promotes tumor invasion via CCL5-CCR5 axis A Beniwal, M Dufault, P Kanvinde, D Nascari, R Eghlimi, A Malla, ... Cancer Research 84 (6_Supplement), 6867-6867, 2024 | | 2024 |
